Subscribe or Manage Preferences

Scleroderma

Results from a recent study demonstrated that myeloablative autologous stem-cell transplantation improved outcomes in patients with severe scleroderma, providing longer-term benefit, superior event-free survival, and overall survival compared with 12 months of cyclophosphamide.


Results 1 - 1 of 1
  • Rheumatology Practice Management
  • Lynx CME
  • American Health & Drug Benefits
  • Value-Based Cancer Care
  • Value-Based Care in Myeloma
  • Value-Based Care in Neurology